Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186169 · ClinicalTrials.gov registry record · NA
Peri-Atrial Inflammatory Fat and Atrial Fibrillation
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04186169: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT04186169 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04186169, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Atrial fibrillation (AF) impacts the lives of 30 million people worldwide. Pulmonary vein isolation (PVI) by catheter ablation is effective for paroxysmal AF, but the success rate remains marginal at 60-80%. For persistent AF, defined as continuous AF that sustains longer than 7 days, the success rate is even lower. The low success rate of AF ablation reflects the fact that there is no effective target identified to modify the underlying substrate beyond PVI. Recently, investigators have made an exciting discovery that higher mean CT attenuation values of peri-atrial fat tissue, correlated with inflammatory fat, are associated with higher incidence of recurrence after AF ablation. In this protocol, investigators will investigate the clinical significance of peri-atrial inflammatory fat tissue in AF using ultra-high resolution CT.
Interventions
- PROCEDURE Catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2024-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04186169
The ClinicalTrials.gov registry entry for NCT04186169 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Catheter ablation is the first listed.
NCT04186169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04186169 about?
NCT04186169 is a clinical study titled "Peri-Atrial Inflammatory Fat and Atrial Fibrillation". Atrial fibrillation (AF) impacts the lives of 30 million people worldwide. Pulmonary vein isolation (PVI) by catheter ablation is effective for paroxysmal AF, but the success rate remains marginal at 60-80%. For persistent AF, defined as continuous AF that sustains longer than 7 days, the success ra...
What is the current status of trial NCT04186169?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-02-19. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT04186169?
The interventions under investigation include: Catheter ablation (PROCEDURE).
Who is sponsoring clinical trial NCT04186169?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.